O2HI34 Stock Overview
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 1/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
+ 1 more risk
Omega Healthcare Investors, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$52.98 |
| 52 Week High | US$57.78 |
| 52 Week Low | US$42.51 |
| Beta | 0.90 |
| 1 Month Change | 2.83% |
| 3 Month Change | 5.96% |
| 1 Year Change | 17.73% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -2.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| O2HI34 | BR Health Care REITs | BR Market | |
|---|---|---|---|
| 7D | 0.2% | -0.3% | -1.6% |
| 1Y | 17.7% | -0.1% | 12.3% |
Return vs Industry: O2HI34 exceeded the BR Health Care REITs industry which returned -1% over the past year.
Return vs Market: O2HI34 exceeded the BR Market which returned 12.4% over the past year.
Price Volatility
| O2HI34 volatility | |
|---|---|
| O2HI34 Average Weekly Movement | n/a |
| Health Care REITs Industry Average Movement | 3.3% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in BR Market | 8.5% |
| 10% least volatile stocks in BR Market | 2.2% |
Stable Share Price: O2HI34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine O2HI34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 57 | C. Pickett | www.omegahealthcare.com |
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.
Omega Healthcare Investors, Inc. Fundamentals Summary
| O2HI34 fundamental statistics | |
|---|---|
| Market cap | R$39.68b |
| Earnings (TTM) | R$1.27b |
| Revenue (TTM) | R$4.99b |
30.4x
P/E Ratio7.7x
P/S RatioIs O2HI34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| O2HI34 income statement (TTM) | |
|---|---|
| Revenue | US$949.74m |
| Cost of Revenue | US$59.58m |
| Gross Profit | US$890.16m |
| Other Expenses | US$647.98m |
| Earnings | US$242.18m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 02, 2024
| Earnings per share (EPS) | 0.99 |
| Gross Margin | 93.73% |
| Net Profit Margin | 25.50% |
| Debt/Equity Ratio | 134.9% |
How did O2HI34 perform over the long term?
See historical performance and comparison